Literature DB >> 6969134

Prevalence of markers of hepatitis B virus infection in various countries: a WHO collaborative study.

O Sobĕslavský.   

Abstract

A WHO collaborative study on viral hepatitis B in which 21 laboratories in 20 countries participated is described. The aim of the study was to define the prevalence of hepatitis B surface antigen (HBsAg), its subtypes, and its antibody (anti-HBs) by age and sex and urban or rural residence in normal populations in different parts of the world. High-risk groups in the populations and patients with various diseases were also investigated. The results of the study confirmed that HBsAg and anti-HBs prevalence rates were higher in African and Asian countries than in the Americas, Australia, and northern and central Europe. Some eastern and southern European countries, however, were also shown to have high HBsAg and anti-HBs prevalence rates, comparable with those in Africa and Asia. In countries with low HBsAg and anti-HBs prevalence, there seems to be a gradual build-up during late childhood or early adolescence, whereas in countries with high HBsAg and its antibody prevalence, they were frequently detected in preschool children. Although the trend was towards a higher frequency of HBsAg and anti-HBs in urban than in rural and in male than in female populations, the differences were in most cases not significant. On the other hand, a significantly higher prevalence of markers of hepatitis B virus infection was seen in high-risk population groups than in normal populations. This was, however, clearly defined only in areas with low HBsAg and anti-HBs prevalence in the normal population. The geographical distribution of HBsAg subtypes showed a higher prevalence of the ad subdeterminant over ay in central European countries, whereas in eastern and southern Europe the ay subtype predominated. In West Africa, ayw was the only variant found, whereas in East Africa ad occurred more frequently than ay. In Australia, both adw and ayw subtypes were detected, whereas in the Far East and South-east Asia only adw and adr were seen.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6969134      PMCID: PMC2395942     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  6 in total

1.  The epidemiology of hepatitis B infections in Africa: results of a pilot survey in the Republic of Senegal.

Authors:  W Szmuness; A M Prince; G Diebolt; L Leblanc; R Baylet; R Masseyeff; J Linhard
Journal:  Am J Epidemiol       Date:  1973-08       Impact factor: 4.897

Review 2.  Recent advances in the study of the epidemiology of hepatitis B.

Authors:  W Szmuness
Journal:  Am J Pathol       Date:  1975-12       Impact factor: 4.307

3.  Transplacental transmission of hepatitis-B virus by symptom-free chronic carrier mothers.

Authors:  G Papaevangelou; J Hoofnagle; J Kremastinou
Journal:  Lancet       Date:  1974-09-28       Impact factor: 79.321

4.  Prevalence of serum-hepatitis-related antigen (SH) in different geographic regions.

Authors:  A M Prince
Journal:  Am J Trop Med Hyg       Date:  1970-09       Impact factor: 2.345

5.  Hepatitis B antigen, antigen subtypes, and hepatitis B antibody in normal subjects and patients with liver disease.

Authors:  K Nishioka; A G Levin; M J Simons
Journal:  Bull World Health Organ       Date:  1975       Impact factor: 9.408

6.  [HBs antigen in rural population of Senegal (author's transl)].

Authors:  J L Oudart; J Roffi
Journal:  Med Trop (Mars)       Date:  1978 Sep-Oct
  6 in total
  28 in total

1.  Hepatitis-B virus infection in sexually transmitted disease clinic attenders in an African city, (Jos, Nigeria)

Authors:  C S Bello; S O Opajobi; S N Okolo; R S Olarewaju; L O Idoko
Journal:  Genitourin Med       Date:  1992-10

2.  Epidemiology of childhood hepatitis B in India: vaccination related issues.

Authors:  L Kant; A J Hall
Journal:  Indian J Pediatr       Date:  1995 Nov-Dec       Impact factor: 1.967

3.  Seroprevalence of hepatitis B infection in Turkish children.

Authors:  N Kuyucu; A Dökmen; A Yöney; T Teziç
Journal:  Infection       Date:  1998 Sep-Oct       Impact factor: 3.553

Review 4.  Epidemiology of chronic viral hepatitis in the Mediterranean area: present status and trends.

Authors:  G B Gaeta; G Giusti
Journal:  Infection       Date:  1990 Jan-Feb       Impact factor: 3.553

5.  Prevalence of anti-delta antibodies in chronic HBsAg carriers in Czechoslovakia.

Authors:  J Stránský; P Jezek; M Zichová; I Kolácný; Z Horák; M Vodák; P Chalupa
Journal:  Infection       Date:  1989 Jul-Aug       Impact factor: 3.553

6.  Epidemiological patterns of hepatitis B virus (HBV) in highly endemic areas.

Authors:  W J Edmunds; G F Medley; D J Nokes; C J O'Callaghan; H C Whittle; A J Hall
Journal:  Epidemiol Infect       Date:  1996-10       Impact factor: 2.451

Review 7.  Infectious diseases in Africa.

Authors:  E A Ayoola
Journal:  Infection       Date:  1987 May-Jun       Impact factor: 3.553

8.  AUSTRALIA ANTIGEN (HBsAG) IN INSTITUTIONALISED SCHIZOPHRENICS.

Authors:  S Chaudhury; S Chandra; G S Chopra; M Augustine
Journal:  Indian J Psychiatry       Date:  1993-01       Impact factor: 1.759

9.  Association of hepatitis B and human immunodeficiency virus infections in Tanzanian population groups.

Authors:  J F Shao; G Haukenes; E Yangi; S E Vollset
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-01       Impact factor: 3.267

10.  Costs and cost-effectiveness of a universal, school-based hepatitis B vaccination program.

Authors:  M Krahn; R Guasparini; M Sherman; A S Detsky
Journal:  Am J Public Health       Date:  1998-11       Impact factor: 9.308

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.